Table 6 Brief of most related ci-miRNAs as lung tumor biomarkers and their clinical consequences [265]
miRNAs | Expression in lung tumor | Clinical correlation |
|---|---|---|
miR-126 | Decreased | It differs among NSCLC and normal groups and is an autonomous damaging predictive agent. |
let-7 | Decreased | It differs among NSCLC and normal groups and is related to shortened survivorship. |
miR-145 | Decreased | It is related to unfavorable prognosis in NSCLC. |
miR-34 | Decreased | Differentiates among LUSC and normal groups and is related to proliferation and recurrence. |
miR-31 | Increased | Related to LUAD patients with lymph node metastasis. |
miR-205 | Increased | Differentiates among NSCLC or LUSC and normal groups. |
miR-221 | Increased | Related to invasion NSCLC, patient recurrence, and stability to TKIs. |
miR-155 | Increased | It differs among NSCLC patients and normal groups and is related to OS. |
miR-210 | Increased | It differs among LUSC and normal groups and is related to enhanced disease-particular survival. |
miR-21 | Increased | It differs among NSCLC or LUAD patients and normal groups. |